£1.5M
The oversubscribed raise was led by investment platform Wealth Club alongside existing backers Deepbridge Capital and Boundary Capital.
Glyconics builds rapid non-invasive diagnostic tools for point-of-care health screening.
Glyconics is a medtech company developing non-invasive point-of-care diagnostic tools using infrared spectrometry. The firm is focused on creating rapid screening solutions for conditions such as diabetes.
Päivi Paldánius
Chief Medical Officer
Kam Pooni
CEO
The oversubscribed raise was led by investment platform Wealth Club alongside existing backers Deepbridge Capital and Boundary Capital.